Business Segments Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 22/04/2026 BST			5-day change	1st Jan Change
1,775.50 ^DKK	+2.51%		-3.66%	-12.41%

04-22	BNP Paribas Upgrades Genmab to Outperform, Boosts PT	MT
04-22	Goldman Sachs Upgrades Genmab to Buy From Neutral, Adjusts Price Target to $30.50 From $24.50	MT

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (DKK)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025 (USD)
Biological Products
Biotechnology						8.48B	14.6B	16.47B	21.53B	3.72B
Total Assets						24.63B	30.28B	35.29B	45.81B	12.87B
Interest Expense						-13M	-21M	-27M	-120M	-61M
Income Tax Expense						975M	1.51B	1.28B	1.32B	241M
CAPEX						-252M	-317M	-366M	-187M	-37M
EBT						3.98B	7.04B	5.64B	9.16B	1.2B
D&A						304M	398M	240M	413M	57M
Operating Income						3.02B	6.36B	5.32B	6.7B	1.06B
Net Income						3.01B	5.52B	4.35B	7.84B	963M

Geographical Revenue Distribution History

Geographical breakdown of sales (DKK)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025 (USD)
Denmark						8.48B	14.6B	16.05B	19.78B	3.33B
Total Assets						269M	211M	496M	12.71B	1.79B
Japan						-	-	41M	841M	213M
Total Assets						95M	70M	56M	100M	12M
Total Assets						-	-	-	48M	6M
United States of America						-	-	380M	902M	180M
Total Assets						470M	442M	378M	3.2B	459M
Netherlands						-	-	-	-	1M
Total Assets						422M	793M	874M	767M	7.51B

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Unlock them now!